and the Eph/ephrin-mediated stalling of spinal motor 110.7 ± 8.4 m; p < 0.01 by ANOVA). However, the numaxons at the base of the limb in vivo. Thus, ephexin1 is ber of neurites per cell was unaltered between wildinvolved in the opposing processes of axonal outgrowth type and ephexin1 −/− neurons (wild-type 3.87 ± 0.22 and growth cone collapse/repulsion. We have eluciversus ephexin1 −/− 4.19 ± 0.11 neurites per cell; p = dated the mechanism by which Ephs control ephex-0.32 by ANOVA). These results suggest that ephexin1's activity to mediate these processes. We find that, in1 plays a crucial role in axon outgrowth. in the absence of ephrin stimulation, ephexin1 activates Our previous study had suggested that ephexin1 RhoA, Rac1, and Cdc42, thus leading to a balance of might play a role in regulating ephrin-induced growth GTPase activity that promotes outgrowth. Ephrin encone collapse in RGCs. To assess the importance of gagement of Ephs leads to phosphorylation of ephexephexin1 for EphA-mediated axon guidance, we comin1 on Tyr87. This phosphorylation event preferentially pared the ability of ephrin-A to induce growth cone activates ephexin1's exchange activity toward RhoA collapse of RGCs obtained from either wild-type or but not Rac1 and Cdc42, thus switching the substrate ephexin1 −/− mice. We used purified RGCs for these expreference of ephexin1 and leading to growth cone colperiments, because both EphAs and ephexin1 are exlapse. These findings reveal a new mode of phosphorypressed in the ganglion cell layer of embryonic and lation-dependent GEF regulation and provide insight early postnatal retina, and the ability of ephrins to mediinto the mechanism by which EphA signaling controls ate growth cone collapse has been well established in the actin cytoskeleton via ephexin1 phosphorylation.
RGCs ( RGCs when compared to wild-type RGCs (data not ephexin family members. In our earlier study, we identified three human homologs of ephexin1 (Shamah et shown). These results suggest that, although the basic cellular machinery that mediates growth cone formaal., 2001). Taking advantage of the recent publication of the human genome sequences, we have now identified tion and collapse is intact in ephexin1-deficient neurons, EphA-mediated growth cone collapse is impaired an additional human ephexin family member (RET/ ARHGEF19). Using the BLAST program to search the in the absence of ephexin1.
Since cultured RGCs from ephexin1 −/− mice have de-EST and genomic databases, we also identified four mouse genes that are highly homologous to the original fects in axonal outgrowth as well as in ephrin-induced growth cone collapse, we asked whether these phenomouse ephexin1. We named these human and mouse genes ephexin2 through ephexin5 based on their setypes would be recapitulated in vivo in ephexin1 −/− mice. However, by axon tracing experiments, we have quence similarity to the original ephexin gene ( Figure  2C ). We now refer to the original isolate as ephexin1 been unable to detect a defect in axon pathfinding in −/− RGCs collapse less efficiently in response to ephrin stimulation. However, there is no difference between wild-type and knockout cells in the percentage of collapsed growth cones following LPA treatment. These data represent three separate experiments in which at least 100 growth cones were scored for each condition. All experiments were scored in a blinded manner. All error bars are SEM; *p < 0.01. (C) Schematic representation of the five murine ephexin family members. The SH3 domain is indicated in blue, the PH domain is indicated in green, the DH domain is indicated in red, and the conserved tyrosine motif at the N terminus is indicated in purple. The numbers on the right indicate the number of amino acids contained in each fulllength ephexin family member. and use the term ephexin family to refer to this group structs reduce c-ephexin protein levels in vitro. To determine whether c-ephexin is required for LMC axons of five mammalian genes. A comparison of the sequence of the five ephexin family members reveals that to stall at the base of the limb, the right side of neural tubes from stage 17 embryos was transfected with they share the same overall structure, including a Dbl homology (DH) domain followed by a pleckstrin homoleither of two c-ephexin shRNA constructs and an EGFP plasmid. To ascertain whether c-ephexin protein was ogy (PH) domain, and a C-terminal SH3 domain. However, the various members of the ephexin family have reduced in transfected neurons, transverse sections through embryos were stained with anti-c-ephexin antiunique N-terminal regions, which are variable in length and have little sequence similarity. Examination of the body and Islet-1/2 antibody, to mark postmitotic motor neurons, followed by quantification of pixel intensity. tissue distribution of the ephexin family members by Northern blot and in situ hybridization revealed that C-ephexin protein levels are reduced in neurons transfected with c-ephexin shRNA/EGFP, compared with only ephexin1 and ephexin5 (also known as Vsm-Rho-GEF [Ogita et al., 2003 ]) mRNA are detected at significontrol conditions ( Figure 3C ). Motor neurons were generated in their appropriate position and number; cant levels in P7 and P21 mouse brain ( Figure S2 demonstrated that ephexin is required for Eph signaling To determine if ephexin protein is differentially exin vivo, we sought to understand the mechanism by pressed in LMC and MMC(m) neurons, we examined its which Ephs signal to ephexin to regulate the actin cydistribution using an anti-chicken ephexin antibody. Entoskeleton. dogenous chicken ephexin (c-ephexin) localizes to LMC neurons but is absent from MMC(m) neurons ( Figure 3A ). This observation raised the possibility that c-ephexin may Eph Kinase Activity Is Required account for the differential responses of these motor for Regulating Ephexin1 axons to ephrins. MMC(m) neurons may extend axons We found that treating cultured RGCs with clustered readily into the ephrin-A5-positive somitic mesoderm ephrin-A1 leads to growth cone collapse and that to because they lack c-ephexin, while LMC axons that exoccur normally this process requires ephexin1. Since press c-ephexin might be prohibited from entering the treatment with clustered ephrins induces the aggregaephrin-expressing limb mesoderm. If LMC axons utilize tion of Ephs, leading to the induction of EphA tyrosine c-ephexin in their inhibitory response, then one would kinase activity, it was possible that either the aggregapredict that the loss of c-ephexin would result in the tion of EphA or the induction of EphA kinase activity premature entry of LMC axons into the limb mesoderm.
was responsible for ephexin1 activation. To determine if the tyrosine kinase activity of Ephs is required for ephexin1 activation, we introduced EphA4 and ephexMotor Axons Sort and Enter the Limb Prematurely When c-Ephexin Levels Are Reduced in1 into fibroblasts and monitored the ability of EphA4 to regulate ephexin1-dependent RhoA, Rac1, and Cdc42 To test whether c-ephexin plays a role in the LMC axon pathfinding, we generated two shRNA constructs diactivation. Fibroblasts provide a facile system for evaluating the effects of EphA and ephexin1 on RhoA, rected against c-ephexin, transfected them into chick neural tubes, and examined their effect on motor neuRac1, and Cdc42 activity, as activation of these Rho family GTPases triggers specific changes in fibroblast ron projections. We first tested the ability of these shRNA constructs to knock down c-ephexin in morphology that can be visualized by phalloidin staining. In fibroblasts, RhoA induces stress fiber formation, HEK293T cells and found that they significantly reduced c-ephexin protein levels compared to control Cdc42 causes filopodia extension, and Rac1 triggers lamellipodia formation and membrane ruffling (Nobes constructs (Figure 3B ), indicating that our shRNA con- Reasoning that sites of phosphorylation that play an important role in regulating ephexin1 function would be To test whether the kinase activity of EphA4 is required for this shift in GEF activity, we generated a point conserved throughout evolution, we identified tyrosine residues within the ephexin family that are conserved mutation in EphA4, which renders it kinase inactive. In contrast to wild-type EphA4, expression of the kinaseand might therefore represent regulatory phosphorylation sites. By comparing the sequences of the five inactive EphA4 did not affect the percentage of ephexin1-expressing cells exhibiting RhoA, Rac1, and Cdc42 mammalian ephexins and the chicken, Drosophila, and C. elegans ephexin orthologs, we identified a single typhenotypes ( Figure 4A ). These findings indicate that rosine corresponding to amino acid 87 (Tyr87) of ephexamino acid. Therefore, we used direct sequencing methods to identify which residue on ephexin1 bein1 that is present in the unique N-terminal region of ephexin1 and is conserved between all ephexin family comes phosphorylated following in vitro incubation with Src. To this end, ephexin1 was phosphorylated in members ( Figure 4B ). Analysis using the Scansite phosphorylation prediction program revealed that Tyr87 lies the presence of [γ-32 P]ATP and Src in vitro, and the tryptic peptide carrying the radioactive phosphate within a stretch of amino acids that form a consensus site for Src family kinase phosphorylation (http://scansite. group was isolated by HPLC. Analysis of this tryptic peptide by Edman degradation confirmed that Tyr87 is mit.edu/). As EphA4 is similar to Src in its substrate preference, we considered the possibility that ephexin1 the site of phosphorylation on ephexin1 ( Figure 4D ). Since several commercially available anti-phosphoTyr87 is a site of phosphorylation by the Eph kinase and/or a Src family member.
tyrosine antibodies failed to detect the phosphorylation of Tyr87 on ephexin1, we generated an anti-ephexin1 To test if Tyr87 can be phosphorylated by Src or EphA4, we incubated recombinant Src or the EphA4 kiphospho-Tyr87-specific antibody to monitor the phosphorylation status of Tyr87 of ephexin1 within cells. To nase domain in the presence of [γ-32 P]ATP and either wild-type ephexin1 or a mutant form of ephexin1 in test the specificity of the anti-ephexin1 phospho-Tyr87 antibody, we compared the antibody's affinity for phoswhich Tyr87 was mutated to phenylalanine (ephexin1-Y87F). Under these conditions, wild-type ephexin1 was phorylated and nonphosphorylated ephexin1 peptides that encompass amino acids 81 to 93 of ephexin1. We efficiently phosphorylated by both Src and the EphA4 kinase domain, but not by trkB ( Figure 4C; Figure S3) .
found that the anti-ephexin1 phospho-Tyr87 antibody binds effectively to phospho-ephexin1 peptide, but not Mutation of Tyr87 to phenylalanine abolishes ephexin1's ability to be phosphorylated by EphA4 and Src.
to nonphosphorylated peptide ( Figure 5A ). To assess whether the anti-ephexin1 phospho-Tyr87 antibody seAlthough these results suggest that Tyr87 is the site of EphA4/Src phosphorylation on ephexin1, it remained lectively recognizes Tyr87 phosphorylation in the context of full-length ephexin, we incubated wild-type possible that mutation of Tyr87 to phenylalanine interferes with the phosphorylation of ephexin1 on a neighboring ephexin1 or ephexin1-Y87F with ATP and recombinant Src and examined the anti-ephexin1 phospho-Tyr87 ankDa band is seen in the neuronal lysates from ephexin1 −/− mice, even though Ephs are activated to the tibody's binding to ephexin1 by Western blotting. We found that the anti-ephexin1 phospho-Tyr87 antibody same extent as in wild-type neurons ( Figure 5D ; data not shown), suggesting that the 75 kDa band recogspecifically detects Tyr87 phosphorylated ephexin1, but not the ephexin1-Y87F mutant or nonphosphorynized by the anti-ephexin1 phospho-Tyr87 antibody upon ephrin-A treatment is the Tyr87 phosphorylated lated wild-type ephexin1 ( Figure 5B) . form of ephexin1. Using this antibody, we found that ephrin-A1 stimulation induces the phosphorylation of
Ephrin Stimulation Results in Rapid Tyrosine Phosphorylation of Ephexin1 in Neurons
Tyr87 on ephexin1 in cultured neurons within 1 min (Figure 5C ). Ephexin1 phosphorylation peaks at 5 min and Given the importance of ephexin1 for ephrin-A-induced growth cone collapse in cultured neurons, we utilized begins to diminish by 30 min ( Figure 5C ; data not shown), paralleling the time course of growth cone colthe anti-ephexin1 phospho-Tyr87 antibody to determine whether ephexin1 is phosphorylated in response lapse and reextension in these cultures. To determine whether ephexin1 Tyr87 phosphorylation can be into EphA signaling in primary neuronal cultures. The anti-ephexin1 phospho-Tyr87 antibody recognized a duced by extracellular stimuli in addition to ephrin-A, we characterized the phosphorylation of ephexin1 on protein of the appropriate molecular weight (75 kDa) in ephrin-A1-treated neurons ( Figure 5C ). To confirm that Tyr87 after exposure of neurons to several other extracellular factors. Ephrin-A1 and ephrin-B3 stimulation inthis protein is ephexin1, we compared lysates from wild-type and ephexin1 −/− neurons. Importantly, no 75 duced ephexin1 phosphorylation, while LPA, Sema-3a,
and Nogo did not induce the phosphorylation of this independently of ephrin stimulation. Since no other agent that we tested was able to induce the phosphorysite, despite the ability of these agents to induce growth cone collapse ( Figure 5E ). Furthermore, other lation of Tyr87 on ephexin1, we sought to induce the phosphorylation of ephexin1 in neurons by blocking stimuli, such as BDNF, EGF, PDGF, and forskolin, did not result in the phosphorylation of ephexin1 on Tyr87 cellular tyrosine phosphatases. We found that pervanadate treatment of cultured neurons induced the phos-(data not shown). These observations demonstrate that ephexin1 Tyr87 phosphorylation occurs specifically in phorylation of ephexin1 on Tyr87 and resulted in strong growth cone collapse response ( Figure 6A ; data not response to ephrin stimulation and correlates with the onset of ephrin-induced growth cone collapse, sugshown). Furthermore, pervanadate-treated RGCs expressing wild-type ephexin1 exhibited an increased fregesting a specific role for this phosphorylation event in the process of Eph-dependent growth cone navigation.
quency of growth cone collapse as compared to those expressing ephexin1-Y87F or vector alone, suggesting that pervanadate-induced phosphorylation of ephexin1 Ephexin1 Is Phosphorylated in Neurons can also stimulate growth cone collapse ( Figure 6A ).
by Src Family Kinases
To the limit of our detection, we see no difference in In vitro, both recombinant Src and the EphA4 kinase subcellular localization or level of expression of wilddomain are able to phosphorylate ephexin1. To assess type ephexin1 and ephexin1-Y87F in RGCs (data not the importance of Src activation for ephrin-A1-induced shown). Furthermore, both wild-type ephexin1 and ephexin1 phosphorylation in vivo, we took advantage of ephexin1-Y87F bind EphA4 to a similar degree (Figure two small molecule inhibitors of the Src family of tyrosine 6B). Thus, the observed difference in growth cone colkinases, PP2 and SU6656. Both PP2 and SU6656, but lapse between wild-type ephexin1 and ephexin1-Y87F not PP3, the inactive analog of PP2, inhibited ephrinwas not a result of the mutant's aberrant localization or A1-induced ephexin1 Tyr87 phosphorylation in cultured inability to bind Eph. Taken together, these data sugrat striatal neurons ( Figure 5F ). To ensure that, at the gest that phosphorylation of ephexin1 at Tyr87 contribconcentrations used, the pharmacological inhibitors utes to Eph-mediated growth cone collapse.
were not inhibiting Eph tyrosine kinases, we titrated the RGCs expressing ephexin1-Y87F did not show deconcentration of the inhibitors to a level that did not creased growth cone collapse compared to RGCs exaffect ephrin-induced Eph phosphorylation in cultured
pressing vector alone in response to either ephrin or neurons. We found that PP2 at 0.5 M and SU6656 at pervanadate treatment. These data suggest that under 1 M were specifically able to inhibit ephexin1 phosthe conditions of these experiments ectopically exphorylation on Tyr87 but did not inhibit Eph tyrosine pressed ephexin1-Y87F may not interfere with the funcphosphorylation ( Figure 5F ). These findings suggest tion of endogenous ephexin1. This may be because the that ephrin-A1 binding to EphA leads to phosphorylaendogenous ephexin1 is found in a stable complex with tion of ephexin1 at Tyr87 by activating Src family ki-
Ephs within cells and is not turned over within the time nases. Consistent with our findings, Drescher and colframe of the growth cone collapse experiments (24 hr). leagues have recently reported that Src family kinases
Alternatively, we may not be expressing ephexin1-Y87F can phosphorylate ephexin1 in cultured neurons in reat high enough levels to interfere with the function of sponse to ephrins (Knoll and Drescher, 2004) . the endogenous ephexin1.
Tyrosine Phosphorylation of Ephexin1 Contributes to Growth Cone Collapse Tyrosine Phosphorylation of Ephexin1 Mediates Cell Positioning in a Chick Spinal Cord To determine whether phosphorylation of ephexin1 at Tyr87 is required for ephrin/Eph-dependent growth
We next examined the role of ephexin1 tyrosine phosphorylation in vivo in the context of neural development cone collapse, we transfected RGCs with wild-type and nonphosphorylatable forms (Y87F) of ephexin1 and anusing the chick embryo. To assess whether ephrin-A/ EphA induction of ephexin tyrosine phosphorylation alyzed the effect of these GEFs on ephrin-induced growth cone collapse. We have previously shown that might be important for the proper development of LMC and/or MMC(m) neurons, we examined the effect of ecectopic expression of ephexin1 significantly potentiates ephrin-mediated growth cone collapse and that topic expression of either wild-type or a nonphosphorylatable mutant form of c-ephexin (c-ephexinY17F) on the GEF activity of ephexin1 is necessary for this effect (Shamah et al., 2001 ). While expression of wild-type the behavior of motor neurons within the neural tube. It was difficult to examine the effect of ephexin on axon ephexin1 or ephexin1-Y87F did not significantly alter the percentage of collapsed growth cones in unstimoutgrowth and guidance because neurons ectopically expressing c-ephexin and EphA4 appear round and ulated RGCs, RGCs expressing wild-type ephexin1 exhibited an increased percentage of collapsed growth do not extend axons. Therefore, we concentrated our analysis on the migration and localization of motor neucones in response to ephrin-A1 as compared to RGCs expressing vector alone ( Figure 6A In contrast, the coexpression of EphA4 with the nonof the DH-PH domain confer substrate specificity on phosphorylatable ephexin1 mutant (Y87F) had no effect ephexin1. Furthermore, coexpression of EphA4 with on ephexin1-Y87F GEF activity toward RhoA ( Figure  8B ). Taken together, these data show that the N termiephexin1-DH-PH does not significantly affect the GEF rectly assessed the effect of phosphorylation of Tyr87 on ephexin1's ability to catalyze the exchange of GDP for GTP on RhoA, Rac1, and Cdc42. We expressed renus of ephexin1 regulates its GEF activity and that the phosphorylation of ephexin1 on Tyr87 increases ephexcombinant ephexin1 and ephexin1-Y87F fused to GST from baculovirus-infected cells and tested the exin1's GEF activity toward RhoA relative to Rac1 and Cdc42. However, the experiments in REF-52 cells rechange activity of ephexin1 before and after in vitro phosphorylation by recombinant Src. In the in vitro GDP flect the balance of all GTPases activated in the cell and thus do not distinguish between the following posrelease assay, increased release of GDP from ephexin1 correlates with increased exchange activity. The exsibilities: (1) phosphorylation of ephexin1 could increase ephexin1's GEF activity toward RhoA and not change change activity of wild-type ephexin1 toward RhoA was enhanced upon in vitro phosphorylation by Src, while its activity toward Rac1 or Cdc42, (2) phosphorylation of ephexin1 could increase ephexin1's GEF activity tothe exchange activity of ephexin1 toward Rac1 and Cdc42 was not significantly altered by Src phosphoryward RhoA while inhibiting its activity toward Rac1 or Cdc42, (3) phosphorylation of ephexin1 could suppress lation ( Figure 8C ). To assess whether the observed effect of Src on the exchange activity of ephexin1 is a ephexin1's GEF activity toward Rac1 or Cdc42 and not change its activity toward RhoA. Any of these three result of phosphorylation, we tested the effect of Src on the ability of ephexin1-Y87F to catalyze exchange phorylated, and under these conditions, Eph bound ephexin1 activates RhoA, Rac1, and Cdc42, leading to of GTP for GDP on RhoA, Rac1, and Cdc42. We found a balance of GTPase activation that promotes axonal that Src had no effect on the exchange activity of ephexoutgrowth. Consistent with this idea, RGCs that lack in1-Y87F. result from local modulation of the actin cytoskeleton such that growth cones turn away from repellents and Discussion toward attractants. The discoveries that ephexin1 is required for axon outgrowth, is regulated by tyrosine In the current study, we have tested the hypothesis that phosphorylation, and when tyrosine phosphorylated ephexin1 is required for ephrin-A-induced growth cone promotes growth cone collapse suggest a mechanism collapse and have elucidated a mechanism by which by which Rho GTPases could control the actin cyephrin-A triggers ephexin1-dependent axon guidance. toskeleton in the highly localized manner that is reWe find that chicken motor neurons in which ephexin quired for accurate growth cone guidance. Since protein has been knocked down by RNAi project preephexin1 is constitutively bound to Ephs, its effects on maturely into the hindlimb, indicating that ephexin Rho GTPases may remain confined to the vicinity of the plays a critical role in Eph-mediated axon guidance in Eph complex. 
